Internal Medicine · Palatka, FL
NPI
1912070269
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
800 Zeagler Dr, Suite 210
Palatka, FL, 32177
Phone (386) 328-8668
Groups this clinician bills Medicare through
Medicare paid, 2024
$104K
1,574 services
Medicare patients, 2024
238
Average age 73
Drug cost, 2024
$1.3M
9,530 prescriptions
Company payments, 2025
$1,003
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Miguel Dejuk was code 99214 (office e&m - established), 796 times for 193 patients. In total Miguel Dejuk billed 1,574 services in 28 codes, and Medicare paid $104K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 796 | 193 | $83.46 | $66K |
| 82962 Clinical Chemistry | Office | 322 | 72 | $3.21 | $1,034 |
| 99213 Office E&M - Established | Office | 208 | 111 | $59.69 | $12K |
| 99233 Hospital E&M - Subsequent | Facility | 65 | 28 | $90.03 | $5,852 |
| 99223 Hospital E&M - Initial | Facility | 32 | 31 | $128.61 | $4,115 |
| 99205 Office E&M - New | Office | 24 | 24 | $131.88 | $3,165 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 16 | 15 | $181.30 | $2,901 |
| 99238 Hospital Discharge Management | Facility | 13 | 11 | $58.59 | $762 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 12 | 11 | $128.44 | $1,541 |
By year: 2022 $152K for 2,025 services; 2023 $130K for 1,701 services; 2024 $104K for 1,574 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 322 | 72 | $3.21 | $1,034 |
Medicare prescription drug claims, 2024
In 2024, the drug Miguel Dejuk prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 926 prescriptions and refills. In total Miguel Dejuk wrote 9,530 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 926 | 926 | 127 | $25K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 510 | 510 | 74 | $13K |
| Mounjaro Tirzepatide | 461 | 504 | 76 | $541K |
| Rosuvastatin Calcium Generic | 340 | 1,003 | 113 | $2,695 |
| Alprazolam Generic | 332 | 336 | 57 | $736 |
| Amlodipine Besylate Generic | 311 | 844 | 93 | $1,504 |
| Tramadol Hcl Generic | 225 | 225 | 32 | $1,668 |
| Omeprazole Generic | 219 | 557 | 60 | $4,347 |
| Metformin Hcl Generic | 196 | 448 | 52 | $894 |
| Diazepam Generic | 196 | 197 | 32 | $1,112 |
| Atorvastatin Calcium Generic | 194 | 517 | 60 | $1,159 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 182 | 210 | 40 | $3,319 |
| Cyclobenzaprine Hcl Generic | 178 | 253 | 34 | $2,304 |
| Gabapentin Generic | 175 | 281 | 41 | $2,337 |
| Levothyroxine Sodium Generic | 163 | 404 | 38 | $1,612 |
Brand drugs: 1,531 claims; generic drugs: 7,974 claims; opioid claims: 1,740.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Miguel Dejuk $1,003 ($1,003 in general payments such as food, travel and fees) from 9 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $277.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 13 | $277 |
| Novo Nordisk Inc NVO | 12 | $195 |
| GlaxoSmithKline, LLC. GSK | 10 | $192 |
| Abbvie Inc. ABBV | 5 | $87.37 |
| Lilly USA, LLC LLY | 5 | $80.19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $69.09 |
| Exact Sciences Corporation EXAS | 3 | $65.48 |
| Vanda Pharmaceuticals Inc. VNDA | 1 | $22.89 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 1 | $13.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.